All the news Showing 10 of 82 articles from: Treatment outcomesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Fewer Australians are dying from hepatitis C, but thousands are still missing out on treatment ABC News / 13 August 2018 Advent of DAAs accompanied by dramatic improvement in survival after HCV-related liver transplant Michael Carter / 18 July 2018 Survival among people with hepatitis C virus (HCV) undergoing liver transplant has improved significantly since the introduction of direct-acting antivirals (DAAs), investigators from Catalonia report in the Journal of Hepatology. Thanks to DAAs, there ... BIDMC researchers develop decision-making tool to benefit patients with HCV Eurekalert Medicine & Health / 20 June 2018 Over 300,000 people waiting for hepatitis C treatment in the United States Keith Alcorn / 20 June 2018 At least 300,000 people were awaiting treatment for hepatitis C by the end of 2016 in the United States, with the lowest rates of treatment observed in the Upper Midwest, ... Fatty liver improves rapidly after hepatitis C cure Michael Carter / 18 June 2018 Liver stiffness and liver fat (steatosis) in people with chronic hepatitis C virus (HCV) infection both improve significantly after treatment with direct-acting antivirals (DAAs) resulting in sustained virological response (SVR), ... Surrey develops hepatitis C model that could help improve treatment Eurekalert Inf Dis / 30 May 2018 Do direct acting antivirals cure chronic hepatitis C? BMJ / 18 May 2018 Does portal hypertension always improve after hepatitis C cure? Keith Alcorn / 10 May 2018 Although portal hypertension improves in the majority of people with hepatitis C and cirrhosis after hepatitis C is cured, not all people experience improvement, and oesophageal varices may continue to ... Fewer non-liver cancers in people treated with DAAs compared to the interferon era Keith Alcorn / 02 May 2018 The risk of non-liver cancer is lower in people treated with direct-acting antivirals (DAAs) than in those treated with interferon and is probably an effect of the improved cure rate ... SVR after HCV therapy reduces extrahepatic mortality, manifestations Healio Hepatology / 01 May 2018 ← First12345...9Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E NAFLD Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds